Table 1 Patient demographic and clinical characteristics stratified according to PPDM-A status.

From: Development of an interpretable machine learning model based on CT radiomics for the prediction of post acute pancreatitis diabetes mellitus

 

PPDM-A (n = 109)

Non-PPDM-A (n = 162)

p value

Age (years)

47.10 ± 12.14

45.12 ± 11.58

0.178

Gender (n, %)

  

0.756

 Male

70/64.2

107/66

 

 Female

39/35.8

55/34

 

Smoking (n, %)

45/41.3

67/41.4

0.990

Drinking (n, %)

36/33

67/41.4

0.166

Severity (n, %)

  

0.076

 Mild

26/23.9

38/23.5

 

 Moderate

53/48.6

97/59.9

 

 Severe

30/27.5

27/16.7

 

Infection (n, %)

13/11.9

1/0.6

< 0.001

Hypertension (n, %)

19/17.4

20/12.3

0.242

Biliary stones (n, %)

 PPDM-A

20/18.3

34/21.0

0.594

 Local complications (n, %)

80/73.4

124/76.5

0.556

 Pancreatic necrosis (n, %)

32/29.4

40/24.7

0.394

 Recurrence (n, %)

42/37.8

48/29.6

0.156

 Fatty liver disease (n, %)

57/52.3

85/52.5

0.977

Hospital stay (days)

10.00 (8.00–14.00)

11.00 (8.00–15.00)

0.651

Ca (mmol/L)

2.25 (2.13–2.36)

2.27 (2.16–2.37)

0.641

Serum amylase (U/L)

119.50 (68.50–377.00)

154.30 (82.00–572.50)

0.167

Lipase (U/L)

176.00 (68.00–502.00)

188.60 (67.00–815.50)

0.208

Pancreatic amylase (U/L)

90.70 (46.45–313.00)

106.00 (49.00–477.00)

0.192

Hs-CRP (mg/L)

43.76 (10.98–106.06)

31.63 (6.96–83.29)

 0.083

WBC (× 109 l−1)

11.46 ± 4.44

12.46 ± 4.73

0.081

Triglyceride (mmol/L)

4.06 (1.71–8.24)

3.04 (1.295–7.77)

0.161

Cholesterol (mmol/L)

4.95 (4.04–6.52)

4.99 (4.06–6.43)

0.719

MCTSI

4 (4–6)

4 (4–6)

0.164

  1. Hs-CRP hypersensitive C-reactive protein, WBC blood cell count, MCTSI modified computed tomography severity index.
Back to article page